Paul Thompson

Austin-based drug developer Cassava Sciences knows its future success is dependent upon positive phase 3 trials for its promising Alzheimer’s drug, simufilam. CEO Remi Barbier thinks the drug could become the biggest blockbuster in pharmaceutical history.

John Mackey, who co-founded Whole Foods Market in 1980 and led the company through its $13.7 billion acquisition by Amazon, plans to step down in 2022.

Cassava Sciences is now conducting phase 3 trials for its lead drug candidate, an Alzheimer’s treatment called simufilam. Skeptics of the company’s research want the FDA to halt those trials to investigate claims of data manipulation. President and CEO Remi Barbier sounded defiant in a recent announ…

The Texas Supreme Court might ultimately decide the fate of this prime downtown Austin site.

Austin’s startup scene is attractive to companies from all over — and the Dallas metro is no exception. Here’s a look at a handful of North Texas startups looking to make waves in the Austin area in 2022.

“I’m incredibly proud of how far we’ve been able to take this,” the CEO said. “Taking a step back, I have realized just how burnt out I am.”

With Omicron in full force, we took the pulse of professionals who typically work and play at SXSW. This in-depth report explores the expectations people have for the big festival in 2022 and looks at how participants and organizers are coming along, in terms of bringing it all together. Also includ…

Headwinds have been predicted for late-stage startups, but so far in Austin the deals just keep getting bigger.

After moving to Austin during the pandemic, Tyler Norwood is laying the foundation for global venture capital firm Antler to grow in the Texas capital. From neighborhood spots in East Austin to late night excursions to Donn’s Depot, the jet-setting executive is finding his groove in the Texas capita…

James Beard Awards are a major honor in the restaurant world. Two Austin chefs just earned the prestigious recognition.